Abound Wealth Management Biomarin Pharmaceutical Inc Transaction History

Abound Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 08, 2024	SELL	$83.81 - $99.0 $29,082 - $34,353	-347 Closed	0 $0
Q4 2023 Aug 08, 2024	SELL	$76.22 - $98.51 $12,118 - $15,663	-159 Reduced 31.42%	347 $33.5 Million
Q3 2023 Aug 08, 2024	BUY	$85.07 - $94.48 $42,194 - $46,862	496 Added 4960.0%	506 $44.8 Million
Q2 2023 Aug 08, 2024	BUY	$86.68 - $100.3 $866 - $1,003	10 New	10 $867,000

620

183M

1.41M

1.31M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Abound Wealth Management with notifications on news.